1. Home
  2. CANG vs CUE Comparison

CANG vs CUE Comparison

Compare CANG & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cango Inc.  each representing two (2)

CANG

Cango Inc. each representing two (2)

HOLD

Current Price

$1.70

Market Cap

116.5M

Sector

Technology

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$32.57

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANG
CUE
Founded
2010
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.5M
124.5M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
CANG
CUE
Price
$1.70
$32.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$120.00
AVG Volume (30 Days)
588.3K
133.9K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
N/A
$27,466,000.00
Revenue This Year
$428.72
N/A
Revenue Next Year
$18.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
195.75
52 Week Low
$0.17
$0.17
52 Week High
$5.55
$45.50

Technical Indicators

Market Signals
Indicator
CANG
CUE
Relative Strength Index (RSI) 81.69 54.46
Support Level $1.18 $24.49
Resistance Level N/A $32.82
Average True Range (ATR) 0.09 4.42
MACD 0.19 -0.19
Stochastic Oscillator 83.18 33.94

Price Performance

Historical Comparison
CANG
CUE

About CANG Cango Inc. each representing two (2)

Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The operations are divided into two reportable segments (i) Bitcoin Mining Business and (ii) International Automobile Trading Business. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: